No Data
Express News | Apellis: New Senior Secured Credit Facility Matures on May 13, 2030
Express News | Apellis Eliminates $366 Million Payment Obligations
Express News | Apellis Pharmaceuticals Refinances Existing Debt With up to $475 Million Non-Dilutive Credit Facility From Sixth Street
Apellis Pharmaceuticals Refinances Existing Debt With Up to $475 Million Non-Dilutive Credit Facility From Sixth Street
Apellis received $375 million in funding at close, with ability to access an additional $100 millionMajority of initial proceeds used to buy out existing SFJ Pharmaceuticals development liability Sign
Analysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), TScan Therapeutics (TCRX)
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Nevro Corp (NVRO) and Apellis Pharmaceuticals (APLS)